John S Barbieri1, Ketaki Bhate1, Kathleen P Hartnett2,3,4, Katherine E Fleming-Dutra2, David J Margolis1,5. 1. Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia. 2. Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia. 3. Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia. 4. United States Public Health Service Commissioned Corps, Rockville, Maryland. 5. Department of Biostatistics and Epidemiology, University of Pennsylvania Perelman School of Medicine, Philadelphia.
Abstract
Importance: Dermatologists prescribe more oral antibiotic courses per clinician than any other specialty, and this use puts patients at risk of antibiotic-resistant infections and antibiotic-associated adverse events. Objective: To characterize the temporal trends in the diagnoses most commonly associated with oral antibiotic prescription by dermatologists, as well as the duration of this use. Design, Setting, and Participants: Repeated cross-sectional analysis of antibiotic prescribing by dermatologists from January 1, 2008, to December 31, 2016. The setting was Optum Clinformatics Data Mart (Eden Prairie, Minnesota) deidentified commercial claims data. Participants were dermatology clinicians identified by their National Uniform Claim Committee taxonomy codes, and courses of oral antibiotics prescribed by these clinicians were identified by their National Drug Codes. Exposures: Claims for oral antibiotic prescriptions were consolidated into courses of therapy and associated with the primary diagnosis from the most recent visit. Courses were stratified into those of extended duration (>28 days) and those of short duration (≤28 days). Main Outcomes and Measures: Frequency of antibiotic prescribing and associated diagnoses. Poisson regression models were used to assess for changes in the frequency of antibiotic prescribing over time. Results: Between 2008 and 2016 among 985 866 courses of oral antibiotics prescribed by 11 986 unique dermatologists, overall antibiotic prescribing among dermatologists decreased 36.6% (1.23 courses per 100 visits) from 3.36 (95% CI, 3.34-3.38) to 2.13 (95% CI, 2.12-2.14) courses per 100 visits with a dermatologist (prevalence rate ratio for annual change, 0.931; 95% CI, 0.930-0.932), with much of this decrease occurring among extended courses for acne and rosacea. Oral antibiotic use associated with surgical visits increased 69.6% (2.73 courses per 100 visits) from 3.92 (95% CI, 3.83-4.01) to 6.65 (95% CI, 6.57-6.74) courses per 100 visits associated with a surgical visit (prevalence rate ratio, 1.061; 95% CI, 1.059-1.063). Conclusions and Relevance: Continuing to develop alternatives to oral antibiotics for noninfectious conditions, such as acne, can improve antibiotic stewardship and decrease complications from antibiotic use. In addition, the rising use of postoperative antibiotics after surgical visits is concerning and may put patients at unnecessary risk of adverse events. Future studies are needed to identify the value of this practice and the risk of adverse events.
Importance: Dermatologists prescribe more oral antibiotic courses per clinician than any other specialty, and this use puts patients at risk of antibiotic-resistant infections and antibiotic-associated adverse events. Objective: To characterize the temporal trends in the diagnoses most commonly associated with oral antibiotic prescription by dermatologists, as well as the duration of this use. Design, Setting, and Participants: Repeated cross-sectional analysis of antibiotic prescribing by dermatologists from January 1, 2008, to December 31, 2016. The setting was Optum Clinformatics Data Mart (Eden Prairie, Minnesota) deidentified commercial claims data. Participants were dermatology clinicians identified by their National Uniform Claim Committee taxonomy codes, and courses of oral antibiotics prescribed by these clinicians were identified by their National Drug Codes. Exposures: Claims for oral antibiotic prescriptions were consolidated into courses of therapy and associated with the primary diagnosis from the most recent visit. Courses were stratified into those of extended duration (>28 days) and those of short duration (≤28 days). Main Outcomes and Measures: Frequency of antibiotic prescribing and associated diagnoses. Poisson regression models were used to assess for changes in the frequency of antibiotic prescribing over time. Results: Between 2008 and 2016 among 985 866 courses of oral antibiotics prescribed by 11 986 unique dermatologists, overall antibiotic prescribing among dermatologists decreased 36.6% (1.23 courses per 100 visits) from 3.36 (95% CI, 3.34-3.38) to 2.13 (95% CI, 2.12-2.14) courses per 100 visits with a dermatologist (prevalence rate ratio for annual change, 0.931; 95% CI, 0.930-0.932), with much of this decrease occurring among extended courses for acne and rosacea. Oral antibiotic use associated with surgical visits increased 69.6% (2.73 courses per 100 visits) from 3.92 (95% CI, 3.83-4.01) to 6.65 (95% CI, 6.57-6.74) courses per 100 visits associated with a surgical visit (prevalence rate ratio, 1.061; 95% CI, 1.059-1.063). Conclusions and Relevance: Continuing to develop alternatives to oral antibiotics for noninfectious conditions, such as acne, can improve antibiotic stewardship and decrease complications from antibiotic use. In addition, the rising use of postoperative antibiotics after surgical visits is concerning and may put patients at unnecessary risk of adverse events. Future studies are needed to identify the value of this practice and the risk of adverse events.
Authors: Tina I Wright; Larry M Baddour; Elie F Berbari; Randall K Roenigk; P Kim Phillips; M Amanda Jacobs; Clark C Otley Journal: J Am Acad Dermatol Date: 2008-09 Impact factor: 11.527
Authors: Kira L Ryskina; Erica Goldberg; Briana Lott; Davis Hermann; John S Barbieri; Jules B Lipoff Journal: JAMA Dermatol Date: 2018-04-01 Impact factor: 10.282
Authors: William Watters; Michael P Rethman; Nicholas Buck Hanson; Elliot Abt; Paul A Anderson; Karen C Carroll; Harry C Futrell; Kevin Garvin; Stephen O Glenn; John Hellstein; Angela Hewlett; David Kolessar; Calin Moucha; Richard J O'Donnell; John E O'Toole; Douglas R Osmon; Richard Parker Evans; Anthony Rinella; Mark J Steinberg; Michael Goldberg; Helen Ristic; Kevin Boyer; Patrick Sluka; William Robert Martin; Deborah S Cummins; Sharon Song; Anne Woznica; Leeaht Gross Journal: J Am Acad Orthop Surg Date: 2013-03 Impact factor: 3.020
Authors: Steven R Feldman; Fabian T Camacho; Jennifer Krejci-Manwaring; Christie L Carroll; Rajesh Balkrishnan Journal: J Am Acad Dermatol Date: 2007-05-10 Impact factor: 11.527
Authors: Brooks A Swanson; Matthew D Carson; Jessica D Hathaway-Schrader; Amy J Warner; Joy E Kirkpatrick; Alexa Corker; Alexander V Alekseyenko; Caroline Westwater; J Ignacio Aguirre; Chad M Novince Journal: FASEB J Date: 2021-11 Impact factor: 5.191
Authors: Ayman Grada; James Q Del Rosso; Emmy Graber; Christopher G Bunick; Linda Stein Gold; Angela Y Moore; Hilary Baldwin; Zaidal Obagi; Giovanni Damiani; Timothy Carrothers; Brian McNamee; Eva Hanze Journal: Dermatol Ther Date: 2021-12-30 Impact factor: 3.858
Authors: Christopher G Bunick; Jonette Keri; S Ken Tanaka; Nika Furey; Giovanni Damiani; Jodi L Johnson; Ayman Grada Journal: Antibiotics (Basel) Date: 2021-04-15